Lucid Diagnostics Inc. (LUCD)
LUCD Stock Price Chart
Explore Lucid Diagnostics Inc. interactive price chart. Choose custom timeframes to analyze LUCD price movements and trends.
LUCD Company Profile
Discover essential business fundamentals and corporate details for Lucid Diagnostics Inc. (LUCD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
14 Oct 2021
Employees
72.00
Website
https://www.luciddx.comCEO
Lishan Aklog
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
LUCD Financial Timeline
Browse a chronological timeline of Lucid Diagnostics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.09, while revenue estimate is $1.36M.
Earnings released on 13 Aug 2025
EPS came in at -$0.10 falling short of the estimated -$0.09 by -11.11%, while revenue for the quarter reached $1.16M , missing expectations by -32.08%.
Earnings released on 14 May 2025
EPS came in at -$0.16 falling short of the estimated -$0.09 by -77.78%, while revenue for the quarter reached $828.00K , missing expectations by -46.31%.
Earnings released on 24 Mar 2025
EPS came in at -$0.19 falling short of the estimated -$0.15 by -26.67%, while revenue for the quarter reached $1.20M , missing expectations by -4.24%.
Earnings released on 13 Nov 2024
EPS came in at -$0.20 falling short of the estimated -$0.16 by -25.00%, while revenue for the quarter reached $1.17M , missing expectations by -17.72%.
Earnings released on 12 Aug 2024
EPS came in at -$0.20 surpassing the estimated -$0.22 by +9.09%, while revenue for the quarter reached $976.00K , missing expectations by -34.05%.
Earnings released on 13 May 2024
EPS came in at -$0.21 surpassing the estimated -$0.27 by +22.22%, while revenue for the quarter reached $1.00M , missing expectations by -18.62%.
Earnings released on 25 Mar 2024
EPS came in at -$0.23 surpassing the estimated -$0.26 by +11.54%, while revenue for the quarter reached $1.04M , missing expectations by -15.45%.
Earnings released on 13 Nov 2023
EPS came in at -$0.24 surpassing the estimated -$0.27 by +11.11%, while revenue for the quarter reached $783.00K , missing expectations by -29.46%.
Earnings released on 14 Aug 2023
EPS came in at -$0.23 surpassing the estimated -$0.32 by +28.13%, while revenue for the quarter reached $159.00K , missing expectations by -74.35%.
Earnings released on 15 May 2023
EPS came in at -$0.24 surpassing the estimated -$0.35 by +31.43%, while revenue for the quarter reached $446.00K , beating expectations by +86.78%.
Earnings released on 14 Mar 2023
EPS came in at -$0.29 falling short of the estimated $0.38 by -176.32%, while revenue for the quarter reached $112.00K , missing expectations by -81.94%.
Earnings released on 14 Nov 2022
EPS came in at -$0.28 surpassing the estimated -$0.40 by +30.00%, while revenue for the quarter reached $76.00K , missing expectations by -82.38%.
Earnings released on 15 Aug 2022
EPS came in at -$0.28 surpassing the estimated -$0.36 by +22.22%.
Earnings released on 11 May 2022
EPS came in at -$0.23 surpassing the estimated -$0.30 by +23.33%, while revenue for the quarter reached $189.00K , missing expectations by -59.17%.
Earnings released on 28 Mar 2022
EPS came in at -$0.32 falling short of the estimated -$0.20 by -60.00%, while revenue for the quarter reached $300.00K , missing expectations by -23.25%.
Earnings released on 23 Nov 2021
EPS came in at -$0.49 falling short of the estimated -$0.32 by -53.12%, while revenue for the quarter reached $200.00K , meeting expectations.
Earnings released on 14 Oct 2021
EPS came in at -$0.17 .
Earnings released on 31 Mar 2021
EPS came in at -$0.10 .
Earnings released on 31 Dec 2020
EPS came in at -$0.07 .
Earnings released on 30 Sept 2020
EPS came in at -$0.05 .
LUCD Stock Performance
Access detailed LUCD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.